Considering that traditional serum biomarkers such as CEA and CA19-9 show limited sensitivity and specificity, the search for new CRC markers, such as ANXA1, SCAT1, SCAT2, and SCAT8, has been initiated [97,98,99]. Here, ANXA1 is linked to colorectal carcinoma.